Number

Milestone Title

WP

Nature

Delivery Date

M1.1

Signed Consortium Agreement

1

Management

0

M2.1

Formation of Ethics committee

2

RTD/Innovation

3

M2.2

Review of partner policies for ethical conduct

2

RTD/Innovation

9

M2.3

Review of legal and ethical literature

2

RTD/Innovation

15

M3.1

Accepatance and QT checking of all DNA samples at CNG & GSF

3

RTD/Innovation

12

M3.2

Transfer of Phase II genotypes to centres

3

RTD/Innovation

12

M4.3

Completion of MAGICS clinic case-control collections

4

RTD/Innovation

12

M5.1

Completion of Phase 1 (whole genome) genotyping

5

RTD/Innovation

6

M5.2

Completion of Phase II genotyping

5

RTD/Innovation

9

M5.4

Identification of novel serum proteins from asthmatics

5

RTD/Innovation

15

M5.5

Identification of novel serum proteins from farmers

5

RTD/Innovation

15

M5.8

Joint Phase II data analysed

5

RTD/Innovation

18

M6.1

Completion of field work for dust and milk validation study

6

RTD/Innovation

15

M6.2

Completion of analyses of milk and dust from validation study

6

RTD/Innovation

15

M8.1

Development of agonists and antagonists fro Toll-like receptors

8

RTD/Innovation

18

M8.2

Completed recruitment of pharmacogenetic study population

8

RTD/Innovation

18

M9.1

Appointment of PhD studentships

9

Training

6

M9.2

Appointment of visiting fellowships

9

Training

6

M9.3

Organisation of workshops

9

Training

6